Advertisement
News
Advertisement

Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco

Tue, 11/16/2010 - 4:36am
Bio-Medicine.Org

NEW YORK, Nov. 16, 2010 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today announced the establishment of the Global Centers for Therapeutic Innovation, an entrepreneurial network of partnerships with leading academic medical centers to transform research and development by accessing leading translational researchers.  The University of California, San Francisco is the first collaboration in the network.

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO)

"The Centers for Therapeutic Innovation represents a truly novel open innovation paradigm, combining the unique advantages of top academic research institutions with Pfizer's leading drug development capabilities and research technologies," said Mikael Dolsten, M.D., Ph.D., president of Pfizer Worldwide Research & Development.  "This new way of engaging leading external scientists is a key component of our R&D strategy.  We are excited to pioneer this approach to seek to translate science into novel proofs of mechanism in a more efficient and accelerated manner to better serve patients," Dr. Dolsten said.

Anthony Coyle, Ph.D., will head Pfizer's Global Centers for Therapeutic Innovation, headquartered in Cambridge, Mass.  Dr. Coyle brings extensive knowledge of the full drug development process to this initiative.  As former Vice President and Global Head of Respiratory, Inflammation, and Autoimmune Research at MedImmune Biologics, a division of AstraZeneca, he advanced research and the clinical biologics pipeline.

"With his keen sense of biotechnology culture, strong scientific leadership and history of building successful collaborations, Anthony Coyle is the ideal person to lead the Centers for Therapeutic Innovation," said Jose-Carlos Gutierrez-Ramos, Ph.D., Pfizer's senior vice president of Wo

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading